References
- Stewart EA. Uterine fibroids. Lancet 2001;357:293-8
- Lethaby A, Vollenhoven B, Sowter MC. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids (review). Cochrane Database Syst Rev 2011;2001:CD000547
- Biglia N, Carinelli S, Maiorana A, et al. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Dev Ther 2014;8:285-92
- Donnez J, Tomaszewski J, Vázquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012;366:421-32
- Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine fibroids in five european countries. Eur J Obstet Gynecol Reprod Biol 2010;152:96-102
- Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Obstet Gynecol 2012;206:211.e1-9
- Côté I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 2002;100:683-7
- Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366:409-20
- Zorginstituut Nederland. Zorginstituut Nederland, 2015. http://www.zorginstituutnederland.nl/. The Netherlands: Ulipristal (Esmya), Accessed January, 2015
- National Health Service Scotland. Scottish medicines consortium ulipristal acetate (esmya). 2016. https://www.scottishmedicines.org.uk/SMC_Advice/Advice/1128_16_ulipristal_acetate_Esmya/ulipristal_acetate_Esmya. Scotland, Accessed: February, 2016
- Donnez J, Hudecek R, Donnez O, et al. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertil Steril 2014;103:359-360
- Donnez J, Vázquez F, Tomaszewski J, et al. Long-term treatment of uterine fibroids with ulipristal acetate ☆. Fertil Steril 2014;101:1565-73.e1-18
- Thurkow AL, Admiraal CF, Emanuel MH, et al. Submucous myomas: Diagnosis and therapy. Gynecol Surg 2007;5:93-102
- (NICE), National Institute of Health and Clinical Excellence. Heavy menstrual bleeding, clinical guideline no. 44. London: NICE, 2007. https://www.nice.org.uk/guidance/cg44/resources/heavy-menstrual-bleeding-assessment-and-management-975447024325. Accessed June, 2015
- Statistics Netherlands. Statistics Netherlands, 2016. https://www.cbs.nl/en-gb. The Netherlands: StatLine- Population, Accessed
- Fernandez H, Farrugia M, Jones SE, et al. Rate, type, and cost of invasive interventions for uterine myomas in Germany, France and England. J Minim Invas Gynecol 2008;16:40-6
- Zorginstituut Nederland. Medicijnkosten. 2016. https://www.medicijnkosten.nl/. The Netherlands, Accessed January 2014
- Hakkaart-van Roijen I, Tan S, Bouwmans CAM. Handleiding voor kostenonderzoek methoden en standaard kostprijzen voor economische evaluaties handleiding voor kostenonderzoek methoden en standaard kostprijzen voor economische evaluaties. 2010 Instituut voor Medical Technology Assessment, Erasmus MC in opdracht van College voor zorgverzekeringen, The Netherlands: ErasmusUniversiteit Rotterdam
- Hak E, Van Loon S, Buskens E, et al. Design of the dutch prevention of influenza, surveillance and management (PRISMA) study. Vaccine 2003;21:1719-24
- Portegijs W, Keuzenkamp S. Nederland deeltijdland: Vrouwen en deeltijdwerk. Den Haag: Sociaal en Cultureel Planbureau, 2008. http://www.flexworkresearch.org/uploads/publication/document/2693/Nederlanddeeltijdland.pdf. Accessed January, 2014
- Friedman AJ, Daly M, Juneau-Norcross M, et al. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Hum Reprod 1994;9:1618-25
- Nagy B, Timár G, Józwiak-Hagymásy J, et al. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. Eur J Obstet Gynecol Reprod Biol 2014;175:75-81
- Tsoi B, Blackhouse G, Ferrazzi S, et al. Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management | CEOR. ClinicoEcon Outcomes Res 2015;7:213-225
- Talaulikar VS, Manyonda IT. Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Adv Ther 2012;29:655-63
- Donnez J, Dolmans MM. Uterine fibroid management: From the present to the future. Hum Reprod Update 2016;22:665-686
- Zimmermann A, Bernuit D, Gerlinger C, et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health 2012;12:6-6874-12-6